David Patience
CIK 1970009 · Chief Financial Officer · last filed 2026-07-06
David Patience is a Chief Financial Officer who has filed 24 SEC Form 4 insider transactions across 3 companies since 2023. The most recent filing shows the insider had shares withheld for taxes covering $65.3K of TLSI on Jul 6, 2026. Across all open-market trades the lifetime net is +$8.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.37M
3
24
$8.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLSI | Chief Financial Officer | 261,107 | $4.33 | $1.13M | $0 | 1 | 2026-07-06 |
| TLSIW | Chief Financial Officer | 275,757 | $0.88 | $242.7K | $32.2K | 5 | 2026-05-18 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Chief Financial Officer | 72,144 | $0.03 | $2.5K | -$23.5K | 18 | 2025-04-02 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-06 | TLSI | Tax (F) | −14,650 | -$65.3K | EDGAR |
| 2026-05-18 | TLSIW | Buy (P) | +7,100 | $17.3K | EDGAR |
| 2026-02-23 | TLSIW | Buy (P) | +3,657 | $15.0K | EDGAR |
| 2025-11-25 | TLSIW | Grant (A) | +65,000 | $0 | EDGAR |
| 2025-08-29 | TLSIW | Grant (A) | — | $0 | EDGAR |
| 2025-08-15 | TLSIW | Grant (A) | +200,000 | $0 | EDGAR |
| 2025-04-02 | Accelerate Diagnostics, Inc (AXDX) Delisted | Mixed | +13,184 | -$4.8K | EDGAR |
| 2025-02-27 | Accelerate Diagnostics, Inc (AXDX) Delisted | Mixed | +965 | -$583 | EDGAR |
| 2024-05-30 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-10 | Accelerate Diagnostics, Inc (AXDX) Delisted | Mixed | +24,172 | -$11.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.